Back    Zoom +    Zoom -
<Results>INNOVENT BIO Swings Loss into Profit of RMB834M in 1H
Recommend
12
Positive
26
Negative
7
INNOVENT BIO (01801.HK) has announced its interim results for the period ended June 2025.

The company's revenue rose by 50.6% YoY to RMB5.953 billion. It also recorded a profit of RMB834 million, compared to a loss of RMB393 million in the same period last year. Its EPS stood at RMB0.51. No dividend was declared.

Related NewsJPM Expects MSCI China Index, CSI 300 Index to Have Potential Upside of 35%, 24% by End-2026

AAStocks Financial News